| |
|
|
Confluent
Surgical CEO Amar Sawhney Wins Entrepreneur
Of The Year® Award
Confluent Surgical, Inc. continues to win accolades and recognition...CEO,
Dr. Amar Sawhney was awarded the New England Regional Ernst & Young Entrepreneur
of the Year Award at the Boston Park Plaza Hotel. Dr. Sawhney received this
prestigious award for his commitment to enhancing the way surgeons seal tissue
and reduce adhesions. |
|
06/19/06
Read
More |
| |
|
|
|
| |
|
|
DuraSeal® Sealant receives CE Mark for Vascular Applications
Confluent Surgical, Inc. announced today that a CE Mark has been granted for the DuraSeal Sealant System for use as a surgical sealant during arterial and venous reconstructions to seal suture lines as an adjunct to standard closure techniques in vascular surgery. |
|
02/02/06
Read More |
| |
|
|
|
| |
|
|
Confluent
Surgical, Inc. Awarded "Best Startup Company" by
MassMedic
Confluent Surgical, Inc., today announced that it has been recognized
by Massachusetts Medical Device industry Council (MassMedic) as the
joint recipient of the Nixon Peabody/Smith & Nephew Medical Device
Innovation Award in the “Best Startup Company” category. |
|
11/02/05
Read
More |
| |
|
| |
|
|
DuraSeal® Sealant
CE Mark for Spine Applications
Confluent Surgical, Inc. announced today at the 2005 EuroSpine Conference
in Barcelona, Spain that a CE Mark has been granted for the DuraSeal
Xact Sealant System for use as a surgical sealant. |
|
09/23/05
Read
More |
| |
|
| |
|
|
DuraSeal® Sealant
CE Mark for Thoracic Applications
Confluent Surgical, Inc. announced today that a CE Mark has been
granted for the DuraSeal Sealant System for use as a surgical sealant
during elective pulmonary resection as an adjunct to standard closure
techniques of visceral pleural air leaks. |
|
09/15/05
Read
More |
| |
|
| |
|
|
FDA
Approves First Cranial Dural Sealant
Confluent Surgical, Inc. announced today that the U.S Food and Drug
Administration (FDA) has approved the DuraSeal™ Dural Sealant
System as the first and only product indicated as an adjunct to sutured
dural repair during cranial surgery to achieve watertight closure. |
|
04/07/05
Read
More |
| |
|
| |
|
|
The
Food and Drug Administration (FDA) today
approved a new product to protect against
leakage of cerebrospinal fluid (CSF) after
brain surgery.
The Food and Drug Administration (FDA) today approved a new product
to protect against leakage of cerebrospinal fluid (CSF) after brain
surgery. |
|
04/07/05
Read
More |
| |
|
| |
|
|
CONFLUENT
SURGICAL, INC. Raises $23 Million in Series-D
Financing.
Confluent Surgical, Inc., today announced that it has completed a
$23 million Series D round of venture funding, led by Three Arch
Partners of Portola Valley, CA. |
|
03/30/05
Read
More |
| |
|
| |
|
|
FDA
Panel Recommends Approval For DuraSeal™ Dural
Sealant
Confluent Surgical, Inc. today announced that the Neurological Devices
Advisory Panel voted to recommend to the U.S. Food and Drug Administration
(FDA) the approval of the DuraSeal™ Dural Sealant System as
an adjunct to sutured dural repair during cranial surgery to achieve
watertight closure. |
|
12/02/04
Read
More |
| |
|
| |
|
|
Confluent
Surgical Completes DuraSeal™ Study
Enrollment and Begins PMA Submission
Confluent Surgical announced the completion of enrollment in the
pivotal multi-center clinical trial intended to support U.S. commercialization
of the DuraSeal™ Dural Sealant System. |
|
02/17/04
Read
More |
| |
| |
|
|
